0
Your cart


TOTAL excl.
TOTAL incl.
Pay

Compliance and Efficiency in the Digital Age

Data review / Data integrity / New regulations / Innovative applications

When?

December 02 & 03, 2025

Where?

Lyon, France

Format?

Conferences, Partner Sessions & Exhibition

Introduction

Digitalization: Are humans the solution or the problem?
In the age of artificial intelligence and SaaS, we are constantly seeking to optimize our processes for greater efficiency and compliance. But in this race for technology, what is the true place of humans?
Come explore this essential question with members of the GIC A3P ecompliance during these days dedicated to the challenges of digitalization. From electronic data review to AI validation, cybersecurity, and augmented reality training, humans will be the common thread throughout our discussions.
We will open the debate by asking ourselves: “How can we integrate humans into IT processes?”
And we will conclude with a round table discussion that will crystallize our thinking: “Should we remove humans to be more efficient and compliant?”
Join us for two days of sharing and reflection led by our A3P group of experts specializing in IT system compliance on the challenges and opportunities of digitalization, always keeping humans at the center. Together, let's rethink the pharmaceutical industry—your vision is essential!

PROGRAM

Related articles

CAPA and Deviations

La Vague 76 / Janvier 2023
CAPA processing is at the heart of the quality system. However, its implementation is difficult on a daily basis, both for the manufacturing laboratory and for its subcontractors and suppliers. The use of an e-QMS is an undeniable advantage in preventing the main deviations encountered. Here we detail these deviations, as well as the advantages and disadvantages of subscription-based or locally installed e-QMS solutions.

EU GMP Annex 1. Implementation of the Contamination Control Strategy

La Vague 83 / Octobre 2024
Since the publication of the update to Annex 1 of Good Manufacturing Practices (GMP) in 2022, Contamination Control Strategy (CCS) has been the focus of attention. This article reviews its structure, details the use of certain guidelines and the use of feedback to implement a clear and effective CCS and support good contamination control.

How to accelerate release using CAPAs?

La Vague 69 / Avril 2021
The purpose of a pharmaceutical company is to sell drugs. This short sentence is actually loaded with meaning and can be interpreted in several ways. On the one hand, production, sales, and marketing staff understand it to mean sales and economic performance, while on the other, quality and regulatory affairs staff understand it to mean drugs and regulatory compliance. Does the pharmaceutical industry have two types of customers?

Ce site utilise des cookies pour optimiser le fonctionnement de la plateforme et, mesurer et cibler nos campagnes publicitaires.